Literature DB >> 23216049

Activity of mesenchymal stem cells in a nonperfused cardiac explant model.

Kirsi Alestalo1, Siri Lehtonen, Fredrik Yannopoulos, Tuomas Mäkelä, Jussi Mäkelä, Kari Ylitalo, Timo Väisänen, Tatu Juvonen, Vesa Anttila, Roberto Blanco Sequeiros, Elisa Lappi-Blanco, Petri Lehenkari.   

Abstract

Stem cell therapy represents a potential novel additional therapy for acute myocardial infarction. Cardiac applications of stem cell therapy are now undergoing clinical trials though many properties, including localization, possible adhesion, and infiltration of the injected stem cells in the myocardium, have not been studied in detail even in vitro. To study these mechanisms in a controlled microenvironment, we developed a model where mesenchymal stem cells (MSCs) were transported into live, cultured cardiac explants for further co-culture. About 10×10(3) porcine MSCs were injected into freshly excised and isolated cardiac explants of the pig. The explants were present in the culture medium for up to 7 days, with the time course of viability of the myocardial tissue, and the migration and the localization of the injected MSCs were analyzed with histological and immunohistological stainings. The myocyte structure was observed to be well preserved, and proliferation of capillaries and myofibroblasts was detected at the explant periphery. There were injected MSCs localized in the capillaries and in contact with the endothelial cells. The migration range and the number of adherent MSCs increased over time, suggesting active movement of MSCs in the explant. Our results suggest that this cardiac explant culture model is a feasible method for studying the effects of stem cells in the myocardium in vitro.

Entities:  

Mesh:

Year:  2013        PMID: 23216049     DOI: 10.1089/ten.TEA.2012.0241

Source DB:  PubMed          Journal:  Tissue Eng Part A        ISSN: 1937-3341            Impact factor:   3.845


  2 in total

Review 1.  Mesenchymal stem cells in cardiac regeneration: a detailed progress report of the last 6 years (2010-2015).

Authors:  Aastha Singh; Abhishek Singh; Dwaipayan Sen
Journal:  Stem Cell Res Ther       Date:  2016-06-04       Impact factor: 6.832

2.  Two novel direct SPIO labels and in vivo MRI detection of labeled cells after acute myocardial infarct.

Authors:  Riikka M Korpi; Kirsi Alestalo; Timo Ruuska; Eveliina Lammentausta; Ronald Borra; Fredrik Yannopoulos; Siri Lehtonen; Jarkko T Korpi; Elisa Lappi-Blanco; Vesa Anttila; Petri Lehenkari; Tatu Juvonen; Roberto Blanco Sequieros
Journal:  Acta Radiol Open       Date:  2017-08-02
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.